# ACCEL-LOADING-ACS Study

> **NCT01354808** · PHASE4 · COMPLETED · sponsor: **Gyeongsang National University Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Platelet Aggregation Inhibitors
- Anti-inflammatory Agent
- Myocardial Reperfusion Injury

## Interventions

- **DRUG:** Dual Anti-Platelet Therapy (DAPT)
- **DRUG:** Triple Anti-Platelet Therapy (TAPT)

## Key facts

- **NCT ID:** NCT01354808
- **Lead sponsor:** Gyeongsang National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-07
- **Final completion:** —
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2013-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01354808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01354808, "ACCEL-LOADING-ACS Study". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01354808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*